April 13, 2012 — Researchers at The Ohio State University (OSU) Wexner Medical Center have successfully used nanotechnology to target a protein that plays a key role in atherosclerosis and inflammation, and say the study is an important advance toward using immunotherapy to simultaneously diagnose and treat cardiovascular disease.
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now